glp 1 receptor agonists and dpp 4 inhibitors Glucagon-like peptide-1 Role of Dipeptidyl Peptidase 4
Description
Identifying major depression using whole-brain functional connectivity: a multivariate pattern analysis
Conclusion Both GLP-1 agonists and SGLT2 inhibitors represent significant advances in Type 2 diabetes care
oxidative stress, calcium, and glutamate toxicity overload may also lead to energy deficiencies, forming a vicious cycle with -synuclein accumulation
DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other?"
doi: 10.1586/17446651.2016.1113129
